Rothberg_Institute_For_Childhood_Diseases

Rothberg Institute for Childhood Diseases

Rothberg Institute for Childhood Diseases

Add article description

The Rothberg Institute For Childhood Diseases is a non-profit organization dedicated to finding a cure for rare childhood diseases such as Tuberous Sclerosis Complex (TSC). The organization was founded by Jonathan Rothberg and his wife in 2002 after their son was born with TSC.[1][2][3][4]

Quick Facts Formation, Founder ...

Located in Guilford, Connecticut, the organization was responsible for the CommunityTSC distributed computing project.

Dr. Rothberg graduated from Yale University in 1991.[3]

CommunityTSC

CommunityTSC Drug Design Optimization Lab (D2OL) was a distributed computing project developed by the Institute to test drug candidates interaction with a target molecule that is essential to the spread of the disease under scrutiny. By evaluating the energy level released by binding a small molecule drug candidate to the surface of a larger Target molecule (D2OL) determines the fitness of the particular candidate to a region of the Target structure known as the Active Site. This process is referred to as docking the drug candidate to the target. D2OL ended on April 15, 2009.

References

  1. [1]
    "Yale Medicine Winter 2007: Alumni". Archived from the original on 2007-05-09. Retrieved 2016-11-14.
  2. [2]
    Pollack, Andrew (2011-01-05). "Taking DNA Sequencing to the Masses". The New York Times. ISSN 0362-4331. Retrieved 2023-02-23.
  3. [3]
    Belli, Brita (2018-03-20). "Alumnus Rothberg enlists students to solve next healthcare challenges". YaleNews. Retrieved 2023-06-20.
  4. [4]
    Pollack, Andrew (2011-01-05). "Taking DNA Sequencing to the Masses". The New York Times. ISSN 0362-4331. Retrieved 2023-06-20.


This article about a United States health organization is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Rothberg_Institute_For_Childhood_Diseases, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.